Vimarsana
Biggest News Aggregation in the World

Nir Altschuler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nir Altschuler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nir Altschuler Today - Breaking & Trending Today

Smith+Nephew to acquire CartiHeal, developer of Agili-C - Vimarsana News

Smith+Nephew to acquire CartiHeal, developer of Agili-C

Smith+Nephew to acquire CartiHeal, developer of Agili-C

Smith+Nephew buying CartiHeal for up to $330m - Vimarsana News

Smith+Nephew buying CartiHeal for up to $330m

A previous deal with US company Bioventus fell through. Israeli company CartiHeal has developed an implant for treating cartilage and joint surface lesions in the knee.

CartiHeal Selling Out to Smith & Nephew for $330 Million - Vimarsana News

CartiHeal Selling Out to Smith & Nephew for $330 Million

Israeli medical device company CartiHeal is getting bought out by the British medical equipment company Smith & Nephew (S&N) in a deal that could be worth as much as $330 million. $180 million will be paid now and up to another $150 million could be paid out if certain requirements are met. In 2022, CartiHeal […]

CartiHeal Announces First Commercial Implantation of Agili-C™ in the US - Vimarsana News

CartiHeal Announces First Commercial Implantation of Agili-C™ in the US

CartiHeal Ltd., developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today announced its first commercial implantation of Agili-C in the US by Dr. Ken Zaslav, a specialist in Orthopedic Surgery and Sports Medicine at Northwell Health in New York City, NY.

Source: yahoo.com
PEREGRINE VENTURES REALIZES USD 500 MILLION EXIT FROM CARTIHEAL FOLLOWING FDA APPROVAL OF IMPLANT FOR TREATMENT OF CARTILAGE AND OSTEOCHONDRAL DEFECTS - Vimarsana News

PEREGRINE VENTURES REALIZES USD 500 MILLION EXIT FROM CARTIHEAL FOLLOWING FDA APPROVAL OF IMPLANT FOR TREATMENT OF CARTILAGE AND OSTEOCHONDRAL DEFECTS

/PRNewswire/ -- Peregrine Ventures, a leading investment firm dedicated to supporting life changing healthcare opportunities, today realized the USD 500...